NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Innoviva

Innoviva

Burlingame, Californiainva.com

Overview

Innoviva is a biopharmaceutical company that manages a portfolio of royalties from healthcare assets and invests in the development and commercialization of new medicines in areas of unmet need.

Year Founded

1996

Portfolio Companies

5

Website

inva.com

Investments

Innoviva investments
CompanyDateStageLead
Beacon BiosignalsApr 2026Series BCo-investor
Beacon BiosignalsNov 2025Series BLead
Gate NeurosciencesMay 2025M&ALead
Gate NeurosciencesDec 2024Convertible DebtCo-investor
ImaginAbSep 2023Series C ExtensionCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBurlingame, California
Year Founded1996

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.